IP Verse

Crispr-Based Genome Modification And Regulation

Patent No. EP3138911 (titled "Crispr-Based Genome Modification And Regulation") was filed by Sigma Aldrich on Dec 5, 2013. The application was issued on Dec 5, 2018.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (9)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MATHYS & SQUIRESep 5, 2019WILDING
POHLMANSep 5, 2019POHLMAN
COOLEY UKSep 5, 2019COOLEY UK
BASFSep 4, 2019EISENFUHR SPEISER
PATENT BOUTIQUESep 4, 2019PATENT BOUTIQUE
BAYER BAYERJun 18, 2019COHAUSZ & FLORACK
VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBBFeb 22, 2019VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB
GRUND IPG PATENTANWALTE UND SOLICITOR PARTG MBBJan 30, 2019GRUND
SCHLICHDec 6, 2018SCHLICH

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3138911

SIGMA ALDRICH
Application Number
EP16183724A
Filing Date
Dec 5, 2013
Status
Revoked
Nov 22, 2024
Publication Date
Dec 5, 2018
External Links
Slate, Register , Google Patents